期刊文献+

miR-26a在动脉粥样硬化发生中的作用 被引量:8

Study on the role of miR-26a in the development of atherosclerosis
原文传递
导出
摘要 目的 MicroRNAs通过调节血管平滑肌细胞(VSMCs)表型转化、增殖、迁移来影响动脉粥样硬化斑块形成,本文探讨miR-26a在动脉粥样硬化发生过程中的作用。方法采用终浓度为50 mg/L的氧化型低密度脂蛋白(ox LDL)诱导VSMCs构建动脉粥样硬化模型;采用real-time PCR检测VSMCs中miR-26a表达;运用western blot检测平滑肌α-肌动蛋白(SMα-actin)和平滑肌肌球蛋白重链(MYH11)蛋白表达;流式细胞仪、Brd U和transwell迁移实验检测VSMCs凋亡、增殖和迁移能力变化。结果 ox LDL诱导VSMCs中miR-26a表达显著升高(3.22±0.21 vs 1.03±0.03,t=10.56,P<0.001),anti-miR-26a转染VSMCs能显著减少ox LDL诱导的miR-26a表达(P<0.05)。功能学实验发现ox LDL显著下调VSMCs分化标志物SMα-actin和MYH11蛋白表达、抑制细胞凋亡、促进细胞增殖和迁移(P<0.05),而anti-miR-26a能够逆转ox LDL对VSMCs的作用(P<0.05)。结论 oxLDL处理的VSMCs中miR-26a异常升高,miR-26a促进VSMCs增殖和迁移并抑制细胞凋亡和分化,提示miR-26a在动脉粥样硬化过程中可能发挥关键作用。 Objective MicroRNAs affect atherosclerosis by regulating phenotype transformation, proliferation and migra- tion of vascular smooth muscle cells(VSMCs). Our studies investigate the role of miR-26a in the development of athero- sclerosis. Methods VSMCs were treated with oxidized low density lipoprotein(oxLDL,50 mg/L) to generate atheroscle- rosis model. The expression of miR-26a was detected by real-time PCR. Western blot was used to determine the expression of smooth muscle α-actin( SM ot-actin) and smooth muscle myosin heavy chain (MYH11 ) protein. Flow cytometry, BrdU and transwell migration assays were used to test apoptosis, proliferation and migration of VSMCs. Results oxLDL led to upregulation of miR-26a expression in VSMCs(3.22 ±0.21 vs. 1.03±0.03 ,t = 10.56 ,P 〈0.05 ). However, anti-miR- 26a significantly reduced oxLDL-mediated upregulation of miR-26a in VSMCs( P 〈 0.05 ). Functional studies found that oxLDL significantly decreased the level of SM α-actin and MYHI 1 proteins,inhibited apoptosis and promoted cell proliferation and migration in VSMCs( P 〈 0.05, respectively). However, the effect of oxLDL on VSMCs were inverted by antimiR-26a(P 〈 0.05, respectively). Conclusion VSMCs that are treated with oxLDL show aberrant upregulation of miR- 26a. MiR-26a promoted cell proliferation and migration of VSMCs. Furthermore, miR-26a inhibited apoptosis and cell differentiation in VSMCs, suggesting that miR-26a may play a critical role in the development of atherosclerosis.
出处 《中华全科医学》 2015年第4期532-534,666,F0003,共5页 Chinese Journal of General Practice
基金 浙江省科技厅基金(2013C37106)
关键词 miR-26a 动脉粥样硬化 VSMCS 增殖和迁移 细胞分化 miR-26a Atherosclerosis VSMCs Proliferation and migration Cell differentiation
  • 相关文献

同被引文献89

  • 1廖玲,邹丽君,刘录山.硫化氢:动脉粥样硬化研究新靶点[J].中国动脉硬化杂志,2015,23(2):201-206. 被引量:2
  • 2仲威,严金川.miR-145在动脉粥样硬化发展中的作用[J].中国动脉硬化杂志,2015,23(5):522-526. 被引量:5
  • 3Anogeianaki A,Angelucci D,Cianchetti E,et al. Athero-sclerosis :a classic inflammatory disease[ J]. INT J Immu-nopathol Pharmacol, 2011, 24 (4) : 817-825.
  • 4Kawamata Y, Fujii R, Hosoya M, et al. A G protein-cou-pled receptor responsive to bile acids [ J] . J Biol Chem,2003, 278 (11) : 9 435-440.
  • 5Pols TW, Nomura M,Harach T,et al. TGR5 activation in-hibits atherosclerosis by reducing macrophage inflammationand lipid loading [ J ]. Cell Metab, 2011,14 ( 6 ):747-757.
  • 6Kida T, Tsubosaka Y, Hori M, et al. Bile acid receptorTGR5 agonism induces NO production and reducesmonocyte adhesion in vascular endothelial cells [ J ]. Arte-rioscler Thromb Vase Biol, 2013,33 (7) : 1 663-669.
  • 7Renga B, Cipriani S,Carino A, et al. Reversal of endothe-lial dysfunction by GPBAR1 agonism in portal hypertensioninvolves a AKT/FOXOA1 dependent regulation of H2S gen-eration and endothelin-1 [ J ]. PLoS One, 2015,10(11): e0141082.
  • 8Pols TW, Noriega LG, Nomura M, et al. The bile acidmembrane receptor TGR5 as an emerging target in metabo-lism and inflammation [ J ]. J Hepatol, 2011,54 ( 6) : 1263-272.
  • 9Maruyama T,Miyamoto Y, Nakamura T,et al. Identificationof membrane-type receptor for bile acids ( M-BAR) [ J ].Biochem Biophys RES Commun, 2002, 298 (5) : 714-719.
  • 10Miyazaki-Anzai S, Masuda M, Levi M, et al. Dual activa-tion of the bile acid nuclear receptor FXR and G-protein-coupled receptor TGR5 protects mice against atherosclerosis[J]. PLoS One, 2014,9 (9) : el08270.

引证文献8

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部